title: Chelerythrine induces reactive oxygen species-dependent mitochondrial apoptotic pathway in a murine T cell lymphoma.
abstract: Chelerythrine is a well-known protein kinase C inhibitor and potential antiproliferative and antitumor pharmacological agent. Chelerythrine inhibits/suppresses the HSF1 phosphorylation by inhibiting PKC and blocks the nuclear migration and subsequent synthesis of hsp70 leading to reduced cell viability and activation of apoptotic machinery. Chelerythrine is also known to enhance the production of reactive oxygen intermediate that is strong activator of apoptosis in high concentration. Therefore, the present study intended to investigate the role of chelerythrine-induced reactive oxygen intermediate on the viability and apoptosis of Dalton's lymphoma cells. Enhanced production of reactive oxygen species in Dalton's lymphoma (DL) cells was observed upon treatment of chelerythrine only which was seen completely abolished on treatment of mitochondrial complex inhibitors rotenone and malonate, and anti-oxidant, N-acetyl-L-cysteine. Increased number of DL cells undergoing apoptosis, as observed by fluorescent microscopy and flow cytometry analysis, in chelerythrine only-treated group was seen that was significantly inhibited on treatment of mitochondrial complex inhibitors and anti-oxidants. Staurosporine, on the other hand, does not lead to enhanced production of reactive oxygen intermediate in DL cells.
authors.affiliation: Centre of Advance Study in Zoology, Faculty of Science, Banaras Hindu University, Varanasi, 221-005, UP, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kumar
authors.forename: Arbind
authors.initials: A
authors.lastname: Acharya
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D053119:Benzophenanthridines / Q000494:pharmacology*; D020169:Caspases / Q000378:metabolism; D045744:Cell Line, Tumor; D045304:Cytochromes c / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D016399:Lymphoma, T-Cell / Q000378:metabolism*; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D051379:Mice; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism*; D008954:Models, Biological; D017382:Reactive Oxygen Species / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D053119:Benzophenanthridines; D017382:Reactive Oxygen Species; D045304:Cytochromes c; D006861:Hydrogen Peroxide; C016299:chelerythrine; D020169:Caspases
references.citation: Adv Exp Med Biol. 2012;748:145-69
references.pmid: 22729857
references.citation: Life Sci. 2009 Mar 13;84(11-12):328-36
references.pmid: 19159629
references.citation: J Mol Biol. 2006 Dec 1;364(3):536-49
references.pmid: 17011577
references.citation: J Mol Cell Cardiol. 2001 Oct;33(10):1829-48
references.pmid: 11603925
references.citation: Int J Biochem Cell Biol. 2011 Sep;43(9):1373-82
references.pmid: 21683152
references.citation: Nucleic Acids Symp Ser (Oxf). 2006;(50):197-8
references.pmid: 17150885
references.citation: J Cell Sci. 2007 Dec 1;120(Pt 23):4155-66
references.pmid: 18032788
references.citation: Biochim Biophys Acta. 1998 Aug 10;1366(1-2):139-49
references.pmid: 9714780
references.citation: Biochimie. 2013 Jun;95(6):1171-6
references.pmid: 23353111
references.citation: Arch Biochem Biophys. 2008 Sep 1;477(1):43-52
references.pmid: 18555791
references.citation: Cytometry A. 2005 Nov;68(1):28-35
references.pmid: 16184612
references.citation: Cancer Res. 1996 Jun 15;56(12):2711-4
references.pmid: 8665499
references.citation: Toxicol Lett. 2003 Dec 15;146(1):37-47
references.pmid: 14615066
references.citation: Arch Biochem Biophys. 2002 Jan 15;397(2):199-205
references.pmid: 11795872
references.citation: J Neurochem. 2004 Sep;90(5):1025-35
references.pmid: 15312158
references.citation: J Bioenerg Biomembr. 2006 Feb;38(1):33-42
references.pmid: 16732470
references.citation: Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008 Nov;24(4):399-404
references.pmid: 21158136
references.citation: Free Radic Biol Med. 1998 Nov 1;25(7):826-31
references.pmid: 9823548
references.citation: Toxicol In Vitro. 2010 Apr;24(3):697-706
references.pmid: 20138138
references.citation: Toxicol In Vitro. 2011 Dec;25(8):1581-7
references.pmid: 21664962
references.citation: Cancer Res. 1994 Apr 1;54(7):1707-14
references.pmid: 7511048
references.citation: Cell Transplant. 2012;21(10):2171-87
references.pmid: 22526333
references.citation: Clin Cancer Res. 2008 Oct 15;14(20):6396-404
references.pmid: 18927278
references.citation: Biol Bull. 2005 Dec;209(3):168-83
references.pmid: 16382165
references.citation: Toxicol In Vitro. 2008 Jun;22(4):1008-17
references.pmid: 18358694
references.citation: Cell Biol Int. 2008 Feb;32(2):271-7
references.pmid: 18029203
references.citation: J Leukoc Biol. 2009 Mar;85(3):427-37
references.pmid: 19106181
references.citation: Cell Death Differ. 2009 Jul;16(7):1030-9
references.pmid: 19390557
references.citation: J Biol Chem. 2003 Mar 7;278(10):8516-25
references.pmid: 12496265
references.citation: Toxicol Lett. 2008 Apr 1;177(3):168-81
references.pmid: 18325696
references.citation: J Biol Chem. 2008 Mar 28;283(13):8423-33
references.pmid: 18230621
references.citation: J Biol Chem. 2003 Sep 19;278(38):36027-31
references.pmid: 12840017
references.citation: FEBS Lett. 1972 Mar 15;21(2):195-198
references.pmid: 11946508
references.citation: Clin Cancer Res. 2000 Feb;6(2):737-42
references.pmid: 10690561
references.citation: Cancer Lett. 2006 Jun 8;237(1):67-75
references.pmid: 16019128
references.citation: Biochim Biophys Acta. 2010 Mar;1800(3):213-22
references.pmid: 19695309
references.citation: Anal Bioanal Chem. 2011 Jun;400(8):2383-90
references.pmid: 21336935